Public Policy Letters, Statements, Legal Briefs, & Other Responses
← Back to all Letters & Statements
-
ACMG Comments on FDA Proposed Rule for Regulation of LDTs
-
ACMG Request to FDA to Extend Comment Period for Proposed Rule on Regulation of LDTs
-
ACMG Comments on CY 2024 Physician Fee Schedule Proposed Rule
-
ACMG & ABMGG Joint Response to Supreme Court Ruling on Affirmative Action
-
ACMG Response to NYS on Proposed Changes to Onsite Work Requirements for Lab Directors
-
ACMG Comment to NCD on Germline Editing and Impact on People with Disabilities
-
ACMG Comments to the CLIAC Regarding Remote Laboratory Work
-
ACMG Response to Senate HELP Committee RFI on Healthcare Workforce Shortages
-
ACMG Response to USPSTF Proposed Research Plan for Lynch Syndrome
-
ACMG Letter Regarding Maryland Medicaid Policy for Carrier Screening